Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2023 | Dec 2023 | Dec 2023 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 14.49B | 14.00B | 13.30B | 13.30B | 13.30B | 13.30B |
Gross Profit | 9.09B | 4.46B | 13.13B | 13.13B | 13.13B | 13.13B |
EBITDA | 1.29B | 1.41B | 1.72B | 1.72B | 1.72B | 1.72B |
Net Income | 877.00M | 959.00M | 1.21B | 1.21B | 1.21B | 1.21B |
Balance Sheet | ||||||
Total Assets | 68.94B | 66.49B | 64.71B | 64.71B | 64.71B | 64.71B |
Cash, Cash Equivalents and Short-Term Investments | 2.10B | 2.56B | 2.51B | 2.51B | 2.51B | 2.51B |
Total Debt | 2.98B | 2.97B | 3.03B | 3.03B | 3.03B | 3.03B |
Total Liabilities | 58.27B | 55.98B | 54.82B | 54.82B | 54.82B | 54.82B |
Stockholders Equity | 10.66B | 10.51B | 9.89B | 9.89B | 9.89B | 9.89B |
Cash Flow | ||||||
Free Cash Flow | 2.44B | 2.48B | 2.19B | 2.19B | 2.19B | 2.19B |
Operating Cash Flow | 2.65B | 2.57B | 2.29B | 2.29B | 2.29B | 2.29B |
Investing Cash Flow | -1.58B | -1.32B | -1.84B | -1.84B | -1.84B | -1.84B |
Financing Cash Flow | -1.09B | -1.12B | -577.00M | -577.00M | -577.00M | -577.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $6.18B | 11.37 | 19.23% | 2.04% | 4.47% | 102.98% | |
76 Outperform | $6.23B | 19.41 | 19.49% | 3.83% | 10.29% | -4.70% | |
75 Outperform | $4.70B | 12.65 | 12.19% | 1.95% | 12.27% | 66.53% | |
73 Outperform | $11.07B | 14.56 | 17.17% | 6.86% | 3.35% | -14.16% | |
72 Outperform | $7.54B | 9.15 | 15.07% | 1.80% | 6.87% | 43.53% | |
68 Neutral | $13.12B | 15.06 | 8.54% | 7.81% | 6.12% | -31.43% | |
61 Neutral | C$15.80B | 6.79 | 15.12% | 5.95% | 22.12% | -7.26% |
On August 12, 2025, CNA Financial successfully closed its offering of $500 million in 5.200% notes due in 2035. This financial move, executed under the company’s shelf registration statement, is expected to impact its financial strategy and stakeholder interests positively.
On August 5, 2025, CNA Financial entered into an underwriting agreement with Wells Fargo Securities, Citigroup Global Markets, and J.P. Morgan Securities for the offer and sale of $500 million in 5.200% notes due 2035. The sale is expected to close on August 12, 2025, and is part of CNA Financial’s strategy to leverage its effective shelf registration statement, potentially impacting its financial operations and market positioning.
On July 3, 2025, CNA Financial entered into a General Release and Separation Agreement with Susan A. Stone, Executive Vice President and General Counsel, with her separation effective no later than July 31, 2025. The agreement includes a payment of $2,250,000 in installments and additional health and welfare benefits. In return, Ms. Stone agreed to non-interference and non-solicitation clauses for 12 months, and to cooperate with ongoing litigation and other matters.